ProfileGDS5678 / 1435812_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 56% 57% 56% 57% 52% 58% 55% 57% 62% 58% 57% 58% 57% 66% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 13.470256
GSM967853U87-EV human glioblastoma xenograft - Control 23.460557
GSM967854U87-EV human glioblastoma xenograft - Control 33.4092256
GSM967855U87-EV human glioblastoma xenograft - Control 43.4107857
GSM967856U87-EV human glioblastoma xenograft - Control 53.2277452
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 13.5873858
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 23.4539755
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 33.4440257
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 43.6932662
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 13.4668558
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 23.4463757
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 33.4492858
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 43.4557857
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 53.9978866